Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib

Combination therapies for the treatment of metastatic melanoma are a matter of debate nowadays. We report on a stage IV metastatic melanoma patient with the BRAF V600 mutation and a large tumor burden initially treated with two cycles of ipilimumab. Due to dramatic disease progression, demonstrated...

Full description

Saved in:
Bibliographic Details
Main Authors: Sachpekidis, Christos (Author) , Hassel, Jessica C. (Author) , Dimitrakopoulou-Strauss, Antonia (Author)
Format: Article (Journal)
Language:English
Published: September-December 2017
In: Hellenic journal of nuclear medicine
Year: 2017, Volume: 20, Issue: 3, Pages: 251-253
DOI:10.1967/s002449910611
Online Access:Verlag, kostenfrei, Volltext: https://www.nuclmed.gr/wp-content/uploads/2017/12/13.pdf
Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1967/s002449910611
Get full text
Author Notes:Christos Sachpekidis MD, Jessica C. Hassel MD, Antonia Dimitrakopoulou-Strauss MD

MARC

LEADER 00000caa a2200000 c 4500
001 1576022544
003 DE-627
005 20240925093305.0
007 cr uuu---uuuuu
008 180605s2017 xx |||||o 00| ||eng c
024 7 |a 10.1967/s002449910611  |2 doi 
035 |a (DE-627)1576022544 
035 |a (DE-576)506022544 
035 |a (DE-599)BSZ506022544 
035 |a (OCoLC)1341010976 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sachpekidis, Christos  |d 1983-  |e VerfasserIn  |0 (DE-588)1099707269  |0 (DE-627)858738651  |0 (DE-576)469338482  |4 aut 
245 1 0 |a Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib  |c Christos Sachpekidis MD, Jessica C. Hassel MD, Antonia Dimitrakopoulou-Strauss MD 
264 1 |c September-December 2017 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a DOI lässt sich nicht aufrufen/05.06.2018 
500 |a Gesehen am 05.06.2018 
520 |a Combination therapies for the treatment of metastatic melanoma are a matter of debate nowadays. We report on a stage IV metastatic melanoma patient with the BRAF V600 mutation and a large tumor burden initially treated with two cycles of ipilimumab. Due to dramatic disease progression, demonstrated on interim 18F-FDG PET/CT, vemurafenib was added in the patients therapeutical scheme. After completion of the concurrent ipilimumab and vemurafenib administration, a third 18F-FDG PET/CT showed an impressive metabolic remission of the metastatic disease, reflecting the potential role of the modality in treatment response evaluation of melanoma patients receiving combination therapies. 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
700 1 |a Dimitrakopoulou-Strauss, Antonia  |d 1963-  |e VerfasserIn  |0 (DE-588)1076688373  |0 (DE-627)835256901  |0 (DE-576)167486055  |4 aut 
773 0 8 |i Enthalten in  |t Hellenic journal of nuclear medicine  |d Thessaloniki : Hellenic Soc. of Nuclear Medicine, 1998  |g 20(2017), 3 vom: Sept./Dez., Seite 251-253  |h Online-Ressource  |w (DE-627)661675270  |w (DE-600)2612539-0  |w (DE-576)345694503  |7 nnas  |a Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib 
773 1 8 |g volume:20  |g year:2017  |g number:3  |g month:09/12  |g pages:251-253  |g extent:3  |a Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib 
856 4 0 |u https://www.nuclmed.gr/wp-content/uploads/2017/12/13.pdf  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1967/s002449910611  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180605 
993 |a Article 
994 |a 2017 
998 |g 1076688373  |a Dimitrakopoulou-Strauss, Antonia  |m 1076688373:Dimitrakopoulou-Strauss, Antonia  |d 910000  |e 910000PD1076688373  |k 0/910000/  |p 4 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 2 
998 |g 1099707269  |a Sachpekidis, Christos  |m 1099707269:Sachpekidis, Christos  |d 910000  |d 910100  |e 910000PS1099707269  |e 910100PS1099707269  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1576022544  |e 3011634378 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Christos Sachpekidis MD, Jessica C. Hassel MD, Antonia Dimitrakopoulou-Strauss MD"]},"id":{"doi":["10.1967/s002449910611"],"eki":["1576022544"]},"recId":"1576022544","physDesc":[{"extent":"3 S."}],"relHost":[{"pubHistory":["1.1998 -"],"origin":[{"dateIssuedKey":"1998","dateIssuedDisp":"1998-","publisherPlace":"Thessaloniki","publisher":"Hellenic Soc. of Nuclear Medicine"}],"note":["Gesehen am 15.10.2021"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng","grc"],"part":{"issue":"3","extent":"3","text":"20(2017), 3 vom: Sept./Dez., Seite 251-253","pages":"251-253","volume":"20","year":"2017"},"title":[{"title_sort":"Hellenic journal of nuclear medicine","title":"Hellenic journal of nuclear medicine"}],"id":{"eki":["661675270"],"zdb":["2612539-0"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"661675270","disp":"Metastatic melanoma response to combination therapy with ipilimumab and vemurafenibHellenic journal of nuclear medicine"}],"person":[{"display":"Sachpekidis, Christos","family":"Sachpekidis","role":"aut","given":"Christos"},{"display":"Hassel, Jessica C.","family":"Hassel","role":"aut","given":"Jessica C."},{"role":"aut","given":"Antonia","family":"Dimitrakopoulou-Strauss","display":"Dimitrakopoulou-Strauss, Antonia"}],"origin":[{"dateIssuedDisp":"September-December 2017","dateIssuedKey":"2017"}],"title":[{"title":"Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib","title_sort":"Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib"}],"note":["DOI lässt sich nicht aufrufen/05.06.2018","Gesehen am 05.06.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} 
SRT |a SACHPEKIDIMETASTATIC2017